INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

79,733 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$139K
900 sh
Apr 16, 2026
Page 1177 of 1994
← PrevNext →
Apr 20, 2026
traded Apr 16, 2026
+4d
SEC Form 4

Evidence

1
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Option exercise · 10b5-1 plan
M$419K
9,443 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

1
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$71K
440 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
WL
Wong Jennifer L.Chief Operating Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$210K
39.2K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
7,080 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
57.3K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M—
2,384 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M$20K
2,437 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
7,454 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Option exercise · 10b5-1 plan
M$49K
1,109 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

0
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Option exercise · 10b5-1 plan
M—
1,109 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M$2,050
2,384 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
ML
Michaels Adam LauranceDirector, Chief Executive Officer
MAMAMama's Creations, Inc.
Grant or award · 10b5-1 plan
A—
82.3K sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$57K
15.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$36K
8,226 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$28K
7,454 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
MD
Munagala DinakarDirector, Chief Executive Officer
BZAIBlaize Holdings, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

0
SA
Saha AnuragCHIEF ACCOUNTING OFFICER
CRWDCrowdStrike Holdings, Inc.
Grant or award · 10b5-1 plan
A—
9,681 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
57.3K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Tax withholding · 10b5-1 plan
F$61K
2,288 sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M—
6,184 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

0
SA
Saha AnuragCHIEF ACCOUNTING OFFICER
CRWDCrowdStrike Holdings, Inc.
Grant or award · 10b5-1 plan
A—
7,260 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
2,437 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
8,226 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M$31K
6,184 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

0
WL
Wong Jennifer L.Chief Operating Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
39.2K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$17K
100 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$39K
7,080 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

52
EJ
Earl JohnPresident
NANAKeystone Private Income Fund
Open-market purchase
BUY$3.00M
30.6K sh
Apr 1, 2026Apr 17, 2026
traded Apr 1, 2026
+16dSEC Form 4

Evidence

47
BD
Ballou-Aares DaniellaDirector
IBEXIBEX Ltd
Open-market sale
SELL$142K
5,843 sh
Mar 13, 2025Apr 17, 2026
traded Mar 13, 2025
+400dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.43M
28.9K sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence

41
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$859K
7,236 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence

41
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$750K
6,284 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence

41
GC
Gerber CharlesTrustee
DHYCREDIT SUISSE HIGH YIELD CREDIT FUND
Open-market purchase
BUY$30K
16.0K sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC Form 4

Evidence

40
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.16M
9,841 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence

39
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$75K
2,806 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence

39
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$55K
2,044 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence

39
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$88K
3,316 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence

39
MB
Manufacturers Life Insurance Co (Bermuda Branch)10% Owner
NANAJohn Hancock GA Senior Loan Trust
Open-market purchase
BUY$5.00M
309.0K sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC Form 4

Evidence